{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T12:27:47Z","timestamp":1786969667004,"version":"build-2736575974"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>Penile carcinoma presents significant treatment challenges due to its rarity. The involvement of pelvic lymph nodes and extranodal extension (ENE) indicates unfavorable prognosis. We intend to assess the effectiveness of adjuvant radiotherapy (RT) in this group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>A retrospective analysis of 27 nonmetastatic penile carcinoma patients treated with adjuvant RT between 2016 and 2022 was carried. Patients exhibiting high nodal involvement based on postoperative histopathology received adjuvant chemotherapy (CT) and RT. Endpoints analyzed were disease-free survival (DFS) and overall survival (OS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The median follow-up was 33.8 months. The majority (82%) had cN2 or cN3 nodal stage at presentation. Neoadjuvant CT was used in five (18.5%) patients. Postsurgical resection, extracapsular nodal extension was identified in 24 (89%) patients. Patients then received CT followed by RT (n = 18, 66.7%), RT alone (n = 4, 14.8%), concurrent CTRT (n = 4, 14.8%), or RT followed by CT (n = 1, 3.7%). Fifty Gray in 25 fractions RT dose was most used. The median time to initiating RT was 28 days. The 3-year DFS and OS were 47% (95% confidence interval (CI) 31.8\u201371) and 47.4% (95% CI 30.9\u201372.9), respectively. Regional recurrences (recurrence at inguinal or pelvic nodal regions) occurred in six patients (22.2%), three of them being in-field recurrences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Adjuvant RT demonstrates potential in reducing locoregional failures for penile carcinoma with pN3 disease. Its integration into multimodal regimens warrants prospective validation to optimize sequencing and patient selection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_419_25","type":"journal-article","created":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T08:00:09Z","timestamp":1786780809000},"page":"482-487","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Assessing the efficacy of adjuvant radiotherapy in penile carcinoma: Retrospective study from a tertiary cancer care center in North India"],"prefix":"10.4103","volume":"22","author":[{"given":"Sahil","family":"Sood","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Homi Bhabha Cancer Hospital, Sangrur, Punjab, Homi Bhabha National Institute, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pragyat","family":"Thakur","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Homi Bhabha Cancer Hospital, Sangrur, Punjab, Homi Bhabha National Institute, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anureet","family":"Kaur","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Homi Bhabha Cancer Hospital, Sangrur, Punjab, Homi Bhabha National Institute, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapas Kumar","family":"Dora","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Homi Bhabha Cancer Hospital, Sangrur, Punjab, Homi Bhabha National Institute, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagarjun","family":"Ballari","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Homi Bhabha Cancer Hospital, Sangrur, Punjab, Homi Bhabha National Institute, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayashree","family":"Deshmukh","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Homi Bhabha Cancer Hospital, Sangrur, Punjab, Homi Bhabha National Institute, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisha","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Homi Bhabha Cancer Hospital, Sangrur, Punjab, Homi Bhabha National Institute, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alok Kumar","family":"Goel","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Homi Bhabha Cancer Hospital, Sangrur, Punjab, Homi Bhabha National Institute, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Homi Bhabha Cancer Hospital, Sangrur, Punjab, Homi Bhabha National Institute, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aishwarya","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Pathology, Homi Bhabha Cancer Hospital, Sangrur, Punjab, Homi Bhabha National Institute, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"R1-20260817","doi-asserted-by":"crossref","first-page":"594","DOI":"10.6004\/jnccn.2013.0075","article-title":"Penile cancer: Clinical practice guidelines in oncology","volume":"11","author":"Clark","year":"2013","journal-title":"J Natl Compr Canc Netw"},{"key":"R2-20260817","article-title":"Edn","year":"2024","journal-title":"presented at the EAU Annual Congress Paris"},{"key":"R3-20260817","doi-asserted-by":"crossref","first-page":"21","DOI":"10.17511\/ijmrr.2014.i01.05","article-title":"A pathologist\u2019s perspective of penile carcinoma \u2013 An institutional study at Indian Red Cross Hospital, Nellore","volume":"2","author":"Latha","year":"2014","journal-title":"Int J Med Res Rev"},{"issue":"(2 Suppl 1)","key":"R4-20260817","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/j.urology.2010.04.008","article-title":"Prognostic factors in penile cancer","volume":"76","author":"Ficarra","year":"2010","journal-title":"Urology"},{"key":"R5-20260817","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1001\/jamaoncol.2017.5608","article-title":"Treatment trends and outcomes for patients with lymph node-positive cancer of the penis","volume":"4","author":"Joshi","year":"2018","journal-title":"JAMA Oncol"},{"key":"R6-20260817","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/bju.15309","article-title":"Long-term multicentre experience of adjuvant radiotherapy for pN3 squamous cell carcinoma of the penis","volume":"128","author":"Ager","year":"2021","journal-title":"BJU Int"},{"key":"R7-20260817","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1016\/j.prro.2022.11.001","article-title":"Optimizing target volume for adjuvant radiation therapy in penile cancer","volume":"13","author":"Khurud","year":"2023","journal-title":"Pract Radiat Oncol"},{"key":"R8-20260817","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ijrobp.2007.09.058","article-title":"Adjuvant radiotherapy and survival for patients with node-positive head and neck cancer: An analysis by primary site and nodal stage","volume":"71","author":"Kao","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R9-20260817","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/jamasurg.2021.2373","article-title":"Long-term efficacy of neoadjuvant chemoradiotherapy plus surgery for the treatment of locally advanced esophageal squamous cell carcinoma: The NEOCRTEC5010 randomized clinical trial","volume":"156","author":"Yang","year":"2021","journal-title":"JAMA Surg"},{"key":"R10-20260817","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.4103\/0973-1482.151945","article-title":"Neoadjuvant chemotherapy with cetuximab for locally advanced penile cancer","volume":"11","author":"Luo","year":"2015","journal-title":"J Cancer Res Ther"},{"key":"R11-20260817","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.brachy.2014.06.003","article-title":"High-dose-rate interstitial brachytherapy for T1-T2-stage penile carcinoma: Short-term results","volume":"13","author":"Sharma","year":"2014","journal-title":"Brachytherapy"},{"key":"R12-20260817","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.clon.2021.10.005","article-title":"Impact of adjuvant treatment in pN3 penile cancer","volume":"34","author":"Khurud","year":"2022","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"R13-20260817","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.juro.2010.06.016","article-title":"Prognostic significance of extranodal extension in patients with pathological node positive penile carcinoma","volume":"184","author":"Graafland","year":"2010","journal-title":"J Urol"},{"key":"R14-20260817","doi-asserted-by":"crossref","first-page":"706531","DOI":"10.3389\/fonc.2021.706531","article-title":"Impact of examined lymph node count and lymph node density on overall survival of penile cancer","volume":"11","author":"Gao","year":"2021","journal-title":"Front Oncol"},{"key":"R15-20260817","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00345-020-03179-y","article-title":"Radiotherapy plus chemotherapy versus chemotherapy alone in penile cancer patients with extracapsular nodal extension after inguinal lymph node surgery: A multi-institutional study","volume":"39","author":"Li","year":"2021","journal-title":"World J Urol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_419_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T12:01:15Z","timestamp":1786968075000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_419_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_419_25","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"2025-02-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}